Now showing items 1-1 of 1

    • Gephyrin and cyp2c9 genetic polymorphisms in patients with pharmacoresistant epilepsy 

      El-Tallawy, Hamdy N.; Abuhamdah, Sawsan; Nassar, Ahmed Y.; Farghaly, Wafaa MA.; Saleem, Tahia H.; Atta, Sara A.; Sayed, Ayat A.; Tohamy, Amal M.; Hassan, Mohammed H. (Dove Medical Press Ltd., 2021)
      Purpose: Gephyrin (GPHN) is an essential protein in the regulation of inhibitory postsy-naptic density and polymorphism in the corresponding gene may have a role in the development of pharmacoresistant epilepsy (PRE). For ...